Journal of Oncology Pharmacy Practice

Article	Citations
Corrigendum to Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review	25
Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use	23
Barriers to opioid use in the Arab world	22
Premedication strategy in cetuximab rechallenge after Grade 2 hypersensitivity reactions	22
Administration of ciprofloxacin through a nasogastric tube in pediatric oncology and stem cell transplantation patients	18
Use of nab-paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience	15
Corrigendum to Lonsurf (trifluridine/tipiracil): assessing the impact of dose related toxicities and progression free survival in (refractory) metastatic colorectal cancer	13
Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?	12
Comparing the effectiveness of biosimilar filgrastim (Nivestim®) versus original filgrastim (Neupogen®) for stem cell mobilization in adult and pediatric healthy donors	12
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia	12
Corrigendum to A review on radiation induced nausea and vomiting: “Current management strategies and prominence of radio sensitizers”	12
The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapy	11
Older adults with colon cancer are not different from younger ones, but treated differently: Retrospective analysis from single centre	11
Liposomal amphotericin for secondary prophylaxis: A systematic review and meta-analysis	11
The clinical and financial impact of remote clinical oncology pharmacist engagement in community-based practices within The US Oncology Network	11
Pharmacist interventions in optimising opioid medication therapy in pain management for palliative care patients: A systematic review	11
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma	10
Factors associated with potentially inappropriate medications in elderly with multiple myeloma	10
Re-use of erlotinib in a patient using osimertinib after erlotinib, case report	10
Brigatinib-associated autoimmune hepatitis: A case report	10
Rationalizing prescription via deprescribing in oncology practice	9
Pro-BNP in the differential diagnosis of dyspnea in patients treated with immune-checkpoint inhibitors: Case Report	9
Medication-related problems among patients with cervical cancers at oncology centers of University of Gondar comprehensive specialized hospital: A hospital-based retrospective study	9
A comprehensive evaluation of the safety of ipilimumab, nivolumab and their combination therapy: A systematic review and network meta-analysis	9
Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers	8

Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot study	8
Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey	8
eviQ Education releases free pharmacy anti-cancer drug course for cancer pharmacists	8
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy	8
Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation	8
Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort	8
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation	8
Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma	8
Management of Nelarabine induced neurotoxicity in a child with T-cell acute lymphoblastic lymphoma	7
Myocardial bridge in a patient with castration-resistant metastatic prostate cancer treated with enzalutamide	7
Response to letter to the editor: Use, response and outcomes of second line chemotherapy in patients with advanced biliary tract cancers	7
Late renal toxicity in patient with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib: A case report and literature review	7
Incidence of immune-related adverse events in U.S. veterans treated with immune checkpoint inhibitors	7
Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program	7
Bendamustine-induced nephrogenic diabetes insipidus – A case report	7
Pharmacological profile and potential drug interactions in ovarian cancer hospitalized patients	7
Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis	7
Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case	7
Retrospective study evaluating immune-related adverse events in cancer patients treated with pembrolizumab	7
Evaluation of the quality of life of adult patients admitted to the bone marrow transplantation unit	7
Safety of intramuscular tixagevimab-cilgavimab (Evusheld®) administration in patients at risk of iatrogenic haematoma due to haematological disorders	7
Pirtobrutinib: A novel non-covalent BTK inhibitor for the treatment of adults with relapsed/refractory mantle cell lymphoma	7
Tyrosine kinase inhibitor-induced immune hemolytic anemia; three different drugs in three separate cases	7
Predictors of community pharmacists’ readiness to manage the effective and safe use of oral anticancer medicines in a developing setting	7
Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia	7
Temporal effect of imatinib adherence on time to remission in chronic myeloid leukemia patients	7
Local and systemic side effects of COVID-19 vaccine in Tunisian cancer patients: A prospective single center study	6
Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy	6
Workflow evaluation of environmental contamination with hazardous drugs during compounding and administration in an UK hospital	6
Optimizing medication therapy in elderly patients: The impact of medication review using STOPP and START criteria version 2	6
In vitro compatibility of admixture solutions of 5-fluorouracil and khapzory (disodium levofolinate) in a single infusion bag	6
Adherence to thalidomide in patients with multiple myeloma: A cross-sectional study in a Brazilian metropolis	6
Perspectives toward biosimilars among oncologists: A Malaysian survey	6
The physical exam’s role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma	6
Safety and efficacy of Vitamin C, Vitamin E, and selenium supplementation in the oncology setting: A systematic review	6
Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis	6
Pneumonitis associated with bortezomib in a patient with multiple myeloma	6
Novel genetic structures associated with adverse response to chemotherapy in breast cancer	6
Vinorelbine-related tetraplegia due to severe peripheral neuropathy	6
Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study	6
Successful use of split-dose intravenous daratumumab in a multiple myeloma patient after a first-dose life-threatening infusion-related reaction	6
Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students	6
Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis	6
Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies	6
Clinical and Economic Impact of Pharmacists’ Intervention on Care of Pediatric Hematology and Oncology Patients	6
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy	6
Investigation of 5-fluorouracil cardiotoxicity in combinational therapy: Influence of risk factors and demographics in a Pakistani population	6
Nivolumab-induced sensory ganglionopathy	6
Life-threatening sustained hypocalcemia following Denosumab use in metastatic prostate cancer	6
Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients	6

Investigation of the frequency of bortezomib neuropathy in patients with multiple myeloma diagnosis with normal and abnormal genetic characteristics	6
Evaluation of cancer drug infusion devices prior to the implementation of a compounding robot	6
Atezolizumab-associated myositis in a patient with unresectable hepatocellular carcinoma	5
Evaluation of awareness about importance of high fever in leukemia and lymphoma patients receiving chemotherapy among healthcare professionals working in pharmacies other than hospital pharmacies: A s	5
Health-related quality of life of women with breast cancer being treated with hormone therapy: A scoping review	5
Developing a flowchart to evaluate the use of Closed System Drug-Transfer Devices with monoclonal antibodies: Focus on the clinical trial setting	5
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer	5
Ocular toxicity following carboplatin chemotherapy for neuroendocrine tumour of the bladder	5
Implementation of pharmaceutical care service to elderly cancer patients in a tertiary care hospital in South India	5
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study	5
A study to assess the impact of pharmaceutical care services to cancer patients in a tertiary care hospital	5
Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity	5
Midostaurin-Associated acute pancreatitis	5
Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation	5
Advancements in the use of nanopharmaceuticals for cancer treatment	5
CAPhO Conference 2023 Abstract Book	5
The effect of examining somatic alterations with NGS in patients with solid tumors, on patient management: A single-center experience in Turkey	5
Mercaptopurine induced myelosuppression in a child with a NUDT15 rs116855232 homozygous variant	5
Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma	5
A room of errors simulation to improve pharmacy operators’ knowledge of cytotoxic drug production	5
Grade 3 cytolysis in a patient with metastatic colorectal cancer consuming a mushroom powder-based alternative therapy	5
Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center	5
Impact of a Pharmacist-Led Hypertension Management Program for Oral Chemotherapy in a Specialty Pharmacy Setting	5
Patterns and predictors of antidepressant prescribing among adults with cancer and depression in ambulatory care settings in the United States	5
Alectinib continuation during COVID 19 ‘antiviral’ treatment: Risk or benefit?	5
Increasing pharmacy productivity and reducing medication turnaround times in an Italian comprehensive cancer center by implementing robotic chemotherapy drugs compounding	5
Outcome of antiemetic prophylaxis among pediatric cancer patients receiving moderate to highly emetogenic chemotherapy at pediatric hemato-oncology ward of Tikur Anbessa specialized hospital: A pr	5
Abstracts	5
Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?	5
Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial	5
Descriptive study of clinical pharmacist interventions in adult hospice and palliative care at a comprehensive oncology center in Jordan	5
Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer	5
Global changes to the chemotherapy service during the covid-19 pandemic	5
Successful Treatment of a 92-Year-Old Classic Kaposi's Sarcoma Man With Ultra-Low Dose Oral Etoposide	5
Residual chemotherapy drugs after flushing infusion lines	5
Biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy	5
Investigating Potential Drug-Drug Interactions in Pediatric and Adolescent Patients Receiving Chemotherapy	4
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring	4
Phosphatidylinositol 3-kinase signaling inhibitors for treatment of multiple myeloma: From small molecules to microRNAs	4
Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: A cross-sectional study	4
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient	4
Quantitative association of educational status and effect of patient counseling among cancer patients: A cross-sectional analysis in a tertiary care hospital in South India	4
Assessment of patients’ knowledge of their treatment with capecitabine at the National Institute of Oncology in Rabat	4
Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient	4
A successful initiation of treatment of Hodgkin's lymphoma with adriamycin-bleomycin-vinblastine-dacarbazine dose reduction in a patient with fulminant hepatic failure and co-infection with human immu	4
Oral lichenoid drug eruption due to osimertinib for lung cancer	4
Evaluation of antibiotic appropriateness at an outpatient oncology centre	4
Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP)	4
The effect of anamorelin (ONO-7643) on cachexia in cancer patients: Systematic review and meta-analysis of randomized controlled trials	4
Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions	4
A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer	4
Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma	4
Characterization of education, technical practices and attitudes of Portuguese pharmacy technicians towards manipulation of cytotoxic drugs	4
Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia	4
Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities	4
Widespread vitiligo and poliosis following ipilimumab–nivolumab combination therapy	4
Analysis of chemical contamination by hazardous drugs with BD HD Check® system in a tertiary hospital	4
Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review	4
Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation	4
Determination of drug–drug interaction in breast cancer patients receiving doxorubicin and cyclophosphamide regimen	4
Two different immune related adverse events occured at pancreas after nivolumab in an advanced RCC patient	4
Cost analysis of daratumumab therapy: Is there a cost benefit to using the recently approved subcutaneous product versus the IV product?	4
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer	4
Multiple cardiotoxicities during osimertinib therapy	4
Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients	4
What patient assessment skills do pharmacist independent prescribers require to prescribe immunomodulators in myeloma?	4
Pharmacists’ practices and views regarding management of sexual health in patients with cancer	4
Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method	4
Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib	4
Abstracts	4
Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units	4
Hydroxyurea- a cost effective treatment in developing countries for Atypical Chronic Myeloid Leukemia (aCML): Case Report of Two Patients	4
Treatment with doxorubicin-based protocol in cardiac involvement diffuse large B-cell lymphoma: A case report	4
Providing medication alternatives during intranasal desmopressin recall	4
Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies	4
Oncology stewardship practice in the United States: A Hematology/Oncology Pharmacy Association national survey	4
Rituximab-induced severe acute thrombocytopenia in a patient with splenic marginal zone lymphoma	4
Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies	4
Development and use of an innovative Gap Finding Tool to create a Pharmaceutical Care Model within a paediatric oncology setting	4
Corrigendum to “Anti-cancer medicine shortages in an oncology tertiary hospital of Pakistan: A five-year retrospective study”	4

Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b	4
Vincristine induced fever in a child with embryonal rhadbomyosarcoma	4
Elotuzumab: Empiric analysis of dexamethasone administration schedule	3
Nephrotic syndrome induced by cetuximab in a patient with metastatic colorectal cancer	3
Innovative strategies for effective paclitaxel delivery: Recent developments and prospects	3
Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison	3
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant	3
Processes and perceptions of chemotherapy supply chain in Ethiopia: A mixed-method study	3
Asparaginase activity monitoring and management of asparaginase hypersensitivity reactions in Canada	3
Adherence to caregiver-administered intravenous immunosuppressant medications in pediatric hematopoietic stem cell transplant	3
Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: A comprehensive review	3
Drug-related problems in cancer patients: A systematic review	3
Assessing floor contamination by antineoplastic agents in a Japanese medical institution specializing in cancer treatment	3
Case of nivolumab-induced delayed adrenal insufficiency during the treatment of renal cell carcinoma	3
Withdrawal pain following patients discontinuing Trk inhibitors	3
Expanding oncology pharmacist teams: Justifying the return on investment	3
Capecitabine induced fingerprint loss: Case report and review of the literature	3
MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: A meta-analysis	3
Productivity and aseptic process evaluation during batch production simulation of intravenous medications using a semi-automated compounding device	3
Assessment of adherence to routine vaccination schedules in oncology patients	3
Post COVID availability of oncology drugs – Is this the new normal on both sides of the Atlantic?	3
Incidence of hand-foot syndrome with protein kinase inhibitors in advanced hepatocellular carcinoma patients who received atezolizumab-bevacizumab combination	3
Liver toxicity with ribociclib in a patient with metastatic hormone receptor positive postmenopausal breast cancer	3
A two-tool assessment of the quality of life of patients with breast cancer using generic and disease-specific tools in a Nigerian teaching hospital	3
Severe acute radiation dermatitis after palbociclib therapy in the setting of palliative radiotherapy	3
Unexpected pancytopenia: Dasatinib induced aplastic anemia in chronic myeloid leukemia	3
Horse antithymocyte globulin test doses and infusion reactions in adults with aplastic anemia: A multicenter retrospective experience	3
Evaluating the efficacy of a premedication regimen including high-dose cetirizine in reduction of hypersensitivity reactions to paclitaxel: A retrospective cohort study	3
Osimertinib induced cardiac failure and QT-prolongation in a patient with advanced pulmonary adenocarcinoma	3
Manual versus automated chemotherapy preparation: A retrospective pharmaco-economic analysis	3
Lenalidomide induced pneumonitis	3
Assessing the impact of chemotherapy-induced nausea and vomiting on patients’ quality of life: An Arabic version of the Functional Living Index-Emesis	3
Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy	3
Determinants of clinic absenteeism in a chemotherapy service of a cancer center located at Rio de Janeiro, Brazil	3
Assessment of chemical contamination by cancer drugs during use of the RIVATM compounding robot: A pilot study	3
Drug-related problems among esophageal, gastric and colorectal cancer patients at the National and referral hospital in Kenya	3
Contribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology	3
A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection	3
Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients	3
Motor “freezing” with oxaliplatin	3
Value of therapeutic drug monitoring of endoxifen in Egyptian premenopausal patients with breast cancer given tamoxifen adjuvant therapy: A pilot study	3
Cost-effectiveness of denosumab in preventing skeletal-related events in bone metastases	3
Evaluation of a decentralized investigational drug service pharmacist in a cancer clinical trial infusion unit	3
Evaluation of proteinuria monitoring practice patterns and treatment implications in patients with cancer receiving bevacizumab products	3
Delayed presentation of vincristine extravasation	3
Smartphone-based application and nurses’ interventions for symptoms monitoring in patients treated with oral anticancer agents: A 1-year follow-up in a tertiary cancer center	3
KRAS-targeted therapy in the treatment of non-small cell lung cancer	3
Pemigatinib-induced nail changes – A case report	3
Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice	3
Analysis of immune-mediated reactions in patients with non-small cell lung cancer treated with nivolumab and its association with effectiveness	3
Preparations of exploration of immediate hypersensitivity to antineoplastic agents: An oncology pharmacy perspective	3
Reduced emergency room visits and improved medication adherence of an integrated oncology pharmaceutical care practice in China	3
Pro-adherence complementary audiovisual educational intervention model for chronic myeloid leukemia patients treated with imatinib mesylate	3
Professional profile in veterinary oncology: A Brazilian nationwide survey	3
The regulatory saga of fedratinib	3
Management and health-related quality of life among patients with prostate cancer in a Kenyan tertiary health facility	3
Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastases	3
Anticancer medicines in Pakistan: An analysis of essential medicines lists	3
Dosing of 7 + 3 induction chemotherapy in a patient with acute myeloid leukemia (AML) and morbid obesity	3
Clinical characteristics and risk factors for oxaliplatin hypersensitivity reactions in patients with colorectal cancer	3
A longitudinal assessment of major mouthwashes used in alleviating pain and xerostomia among advanced nasopharyngeal carcinoma patients receiving chemoradiotherapy	3
Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors	3
Rituximab biosimilar HLX01 versus reference rituximab in the treatment of diffuse large B-cell lymphoma: Real-world clinical experience	3
Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards	3
Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology	3
Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors	3
Associations of readiness for hospital discharge with symptoms and non-routine utilization of post-discharge services among cancer patients receiving oral chemotherapy at home: A prospective study	3
Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome	3
Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic	3
Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners	3
Nivolumab for newly and recurrent glioblastoma multiforme treatment: A systematic review and meta-analysis	3
Trastuzumab-induced optic neuritis: “blindness” side effect	3
Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers	3
Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review	3
Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel	3
Enteral tube administration of extemporaneously compounded suspensions of venetoclax according to an institutional medication use process	3
Factors affecting medication adherence in patients using oral chemotherapy: A descriptive study	3
Modified monitoring of abiraterone acetate-induced hepatotoxicity in prostate cancer patients	3
Knowledge and practices about safe handling regarding the risk of exposure to antineoplastic drugs for caregivers in compounding units and in operating rooms performing HIPEC/PIPAC	3
Patient satisfaction and behavioural intention in using the home medication delivery service in an ambulatory oncology centre	3
Influence of the implementation of a multidisciplinary consultation program on adherence to the first ever course of oral antineoplastic treatment in patients with cancer	3
Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer	3
MTHFR 677T-1298C haplotype in acute lymphoblastic leukemia: Impact on methotrexate therapy	3
Managing medications for patients with cancer and chronic conditions: It's time for collaboration between primary care and oncology pharmacists	3
Use of long-term corticosteroids in patients treated with CAR T-cell therapy	3
Impact of telephone follow-up on hepatocellular carcinoma patients receiving oral chemotherapy from an ambulatory-care setting	2
Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer	2
Medication-related osteonecrosis of the jaw in patients with cancer using zoledronic acid and denosumab: Single-center retrospective study	2
Impact of pharmacist managed oral epidermal growth factor receptor inhibitors	2
Chemotherapy regimen for recurrent uterine leiomyosarcoma	2
CAPhO Conference 2024 Abstract Book	2
Anthracyclines in a patient with acute leukemia and severe cardiomyopathy requiring mechanical support: A case report	2
Tamoxifen induced maculopathy presenting like macular telangiectasia type 2 in a patient with breast cancer	2
Abiraterone acetate-associated QT prolongation and torsades de pointes: Postmarketing cases reported to FDA	2
Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab	2